2003
DOI: 10.1504/ijbt.2003.004104
|View full text |Cite
|
Sign up to set email alerts
|

The collaborative economy of biotechnology: alliances, outsourcing and R&D

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 54 publications
0
1
0
Order By: Relevance
“…However, a tradeoff may exist between the corporate need to reduce costs in the short-run and the strategic importance of directly controlling R&D activity in the long run, especially for firms in high-tech sectors (Suárez-Villa and Walrod 2003). Studying the French industry, other authors argue that contractors are likely to subcontract standardized R&D tasks (rather than novel technology) because the TC associated with these routine tasks are probably low (Dhont-Peltrault and Pfister 2011).…”
Section: Empirical Research On Subcontracting Outcomesmentioning
confidence: 99%
“…However, a tradeoff may exist between the corporate need to reduce costs in the short-run and the strategic importance of directly controlling R&D activity in the long run, especially for firms in high-tech sectors (Suárez-Villa and Walrod 2003). Studying the French industry, other authors argue that contractors are likely to subcontract standardized R&D tasks (rather than novel technology) because the TC associated with these routine tasks are probably low (Dhont-Peltrault and Pfister 2011).…”
Section: Empirical Research On Subcontracting Outcomesmentioning
confidence: 99%